论文部分内容阅读
目的:分析小儿肺热咳喘颗粒治疗小儿肺炎40例病例资料。方法:选择2015年10月-2016年2月我院收治的40例小儿肺炎患者为研究对象,将患儿分成两组,对照组患者实施常规西医治疗,以此作为基础,观察组患者使用小儿肺热咳喘颗粒加以治疗,对比两组患者治疗结果和临床症状消失时间。结果:观察组患者无论是在治疗结果还是临床症状消失时间上,均好于对照组,组间数据存在统计学差异,P<0.05。结论:对于小儿肺炎患者,以常规治疗为基础,使用小儿肺热咳喘颗粒,可提升疗效,提高安全性,促进病情转归,值得进一步在临床治疗中推广应用。
Objective: To analyze the data of 40 cases of pediatric pneumonia treated by Hyperactivity and Coughing in Children. Methods: Forty children with pneumonia admitted in our hospital from October 2015 to February 2016 were selected as the study subjects. The children were divided into two groups. The control group received routine Western medical treatment. Based on this, the observation group was treated with pediatric pneumonia Hyperactivity cough particles to be treated, compared the results of two groups of patients and clinical symptoms disappear time. Results: The observation group was better than the control group both in treatment outcome and disappearance of clinical symptoms, with statistical difference between the two groups (P <0.05). Conclusion: For children with pneumonia, the conventional treatment based on the use of Hyperactivity Kechuan granules, can enhance the efficacy and improve safety and promote the prognosis of disease, it is worth further promotion in the clinical treatment.